• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25RWC W/ RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION STERILE FX25RWC W/ RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3CX*FX25RWC
Device Problem Defective Component (2292)
Patient Problem Injury (2348)
Event Date 12/03/2019
Event Type  Injury  
Manufacturer Narrative
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, the arterial line manifold sampling of the oxygenator did not work.There was reported patient injury but now in good condition.The customer did not specify the injury and terumo cardiovascular continues attempt to obtain more information.The product was changed out.Procedure completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on december 27, 2019.Upon further investigation of the reported event, the following information is new and/or changed: d4: (additional device information: added expiration date).G4: (date received by manufacturer).G7: (indication that this is a follow-up report).H2: (follow-up due to additional information).H4: (device manufacture date).H6: (identification of evaluation codes 11, 3331, 4114, 3221, 4315).Method code #1: 11 - testing of device from same lot/batch retained by manufacturer.Method code #2: 3331 - analysis of production records.Method code #3: 4114 - device not returned.Results code: 213 - 3221 - no findings available.Conclusions code: 4315 - cause not established.The affected sample was not returned so a thorough investigation was not able to be conducted.The manifold from a representative retention sample was reviewed and tested to ensure it worked appropriately.The retention sample was setup into a water circuit with water flow through the manifold assembly.The stopcocks were operated and functioned as expected and water flowed through the assembly as expected.Due to the details provided with this complaint, it is not possible to determine a root cause for this event.It's most likely that the manifold assembly was damaged at some point in handling, however, when or how it was damaged is not able to be determined with the provided information.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: h6 (identification of evaluation codes 10, 170, 25).Method code: 10 - testing of actual/suspected device.Results code: 170 - manufacturing process problem identified.Conclusions code: 25 - cause traced to manufacturing.The affected sample was inspected upon receipt with no visual anomalies noted.Water was able to pass through the affected line.Initially, water flowed slowly them stopped.Disassembly of the line found that excessive bonding agent was in the connector.The manifold from a representative retention sample was reviewed and tested to ensure it worked appropriately.The retention sample was setup into a water circuit with water flow through the manifold assembly.The stopcocks were operated and functioned as expected and water flowed through the assembly as expected.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STERILE FX25RWC W/ RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
MDR Report Key9525669
MDR Text Key173304619
Report Number1124841-2019-00347
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier00699753450837
UDI-Public(01)00699753450837
Combination Product (y/n)N
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup
Report Date 03/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2022
Device Model Number3CX*FX25RWC
Device Catalogue NumberN/A
Device Lot NumberXM07
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2020
Was the Report Sent to FDA? No
Date Manufacturer Received02/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-